Wed, Jul 30, 2014, 12:03 AM EDT - U.S. Markets open in 9 hrs 27 mins


% | $
Click the to save as a favorite.

American Capital Agency Corp. Message Board

innsbrooklad 402 posts  |  Last Activity: 1 hour 47 minutes ago Member since: Nov 11, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • innsbrooklad by innsbrooklad 1 hour 47 minutes ago Flag

    " Enteromedics, THE developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders."

    Contrary to the #$%$ spewed by the useless crowd there is a lot more under the hood than they have ever said.
    This is not a one trick pony with a device to lose weight. Their technology is advanced and you would be a fool to think they are so one dimensional. With the Mayo Clinic right down the street, do you really think the inquiry stopped at fat people???

    Take a look at their patent estate. They are going to await FDA approval, license the obesity device for a ton and surprise us with new groundbreaking science. To think this is a one trick pony??? You are daft!

  • Reply to

    The War Has Just Started

    by grumpy_butt 10 hours ago
    innsbrooklad innsbrooklad 9 hours ago Flag

    Nothing has changed. It is called disclosure. If there is a material fact the company must disclose.
    Right now it is institutional shorts scaring the #$%$ out of retail longs. Nothing has happened except they are starting to get thin skinned retail who was looking for a big gain to #$%$ in their pants.
    There is nothing forthcoming from the company until they have an FDA decision. Stop whining will a lot of you. Grumpy Retail never buys when the price falls. They hate looking at losses. I am buying the calls which are so cheap they are a joke.

  • Reply to

    Earnings Call?

    by kelvin_archer Jul 28, 2014 4:27 PM
    innsbrooklad innsbrooklad Jul 28, 2014 8:57 PM Flag

    I was told September..90 days after the Adcom meeting and it is a device not a drug so the FDA does not have that difficult of a time. ETRM is in constant contact with them I have to believe as two of the execs at ETRM have FDA expertise.

    But with the FDA nothing would surprise me.

  • Reply to

    Earnings Call?

    by kelvin_archer Jul 28, 2014 4:27 PM
    innsbrooklad innsbrooklad Jul 28, 2014 4:46 PM Flag

    1. What earnings? 2. What can they say being in the application zone? 3. Does it really matter?
    4. Assume if it gets approved they will need a minimum of $100 MM to get the thing off the ground.
    5. I would love to know what else they are working on,

    I assume there is a lot they cannot say, especially the 24 month results.

    Kelvin...what is important is the next 45 days when we hear from the FDA.

  • innsbrooklad innsbrooklad Jul 28, 2014 2:07 PM Flag

    Shorts do not care. They are just throwing stock between themselves hoping to shake real shares out.
    It is a tough time as the company can say very little. Few more weeks and the fame will change. Wall Street by the way is only trading stuff they can get out of and all the flamers like CMG. Look at Polo Loco. Lets just keep fattening up the country. More for ETRM. I made the mistake of walking into WalMart today. I thought
    I was in a herd of elephants. We are one fat country..

    And also the shorts? It is mostly not their money and until news comes out they can just do what they want.
    There will be no serious buyers until the FDA approves the device. Go to the beach.

  • Reply to


    by patwalsh54 Jul 28, 2014 9:52 AM
    innsbrooklad innsbrooklad Jul 28, 2014 11:43 AM Flag

    Why do you buy when management is the problem. They are going to finance Pat. Mulroy can't get a deal done
    and since 121 was returned he has zero leverage. They have not even filed an NDA for 298. You have a lot of time I think to buy. Might get lucky in the $3s!

  • innsbrooklad by innsbrooklad Jul 28, 2014 7:44 AM Flag

    Today's Wall Street Journal features and article written by Dr. Kevin Tracey, a prominent neurosurgeon who was cited in the New York Times Magazine article in May. While it is opinion piece criticizing the FDA for its archaic
    rules and glacial movement, it does highlight the success of his bioelectric treatment for rheumatoid arthritis and its very obvious success. If it works for rheumatoid arthritis, the path for obesity cures via the same route
    seem very straight forward.

  • innsbrooklad innsbrooklad Jul 27, 2014 6:30 PM Flag

    1 in 5 people in the UAE is obese. That sounds like a pretty good market to start.
    The device is going to be really big. Insurance will cover it within weeks of FDA approval as that is what I imagine the company is working on now. There is nothing out there. Look at ARNA and VVUS stock prices.
    You are not going to need pills...ever.

  • innsbrooklad innsbrooklad Jul 27, 2014 5:15 PM Flag

    Found it.." The National " a Google alert..great article and we get some ink..

  • innsbrooklad innsbrooklad Jul 27, 2014 4:58 PM Flag

    where was the article....I also agree. This is a huge area and ETRM has the patents and if they play it smart they can continue and sell the obesity gadget for royalties. There is so much more in this company that they never talk about.

  • Reply to

    Re: Approval Prospects

    by rolltide2817 Jul 26, 2014 9:57 PM
    innsbrooklad innsbrooklad Jul 27, 2014 10:49 AM Flag

    You forgot 6-2 on benefit versus risk. They did a first of a kind trial set up by the FDA where a sham device was used. You should research this. At the ADCOM subsequent 18 month data was presented which clearly beat the 10% superiority threshold set by the FDA. That was all the committee had to use as a reference.In truth some members said the trial was too short and some said they were not qualified to look at the efficacy even though they all voted. This is a first in class device where it was judged for safety and efficacy which put it in the category of a therapeutic. Other than a Pacemaker which is placed in an organ ( Vbloc stay outside the stomach ) The 24 month data which has the VBLOC over 17 1/2 higher than the placebo is in the FDA's hands.
    Chances of approval..80/20....But do some research and you will feel better.

  • Reply to


    by innsbrooklad Jul 22, 2014 5:11 PM
    innsbrooklad innsbrooklad Jul 25, 2014 9:14 PM Flag

    Ask Godot..He has been waiting forever...

  • Reply to


    by innsbrooklad Jul 22, 2014 5:11 PM
    innsbrooklad innsbrooklad Jul 25, 2014 9:29 AM Flag

    Wait until they toss Mulroy and most of the Board.Management kills this compnay

  • Reply to

    Long term capital gains contributing to swoon

    by canphan7 Jul 23, 2014 12:37 PM
    innsbrooklad innsbrooklad Jul 24, 2014 4:53 PM Flag

    Long term capital gains???? It is July...And they hold for a year and make $1.00??
    You are out of your element pal. Not a fact. Common sense, Which you obviously do not possess.

  • Reply to

    too much scrutiny on the company

    by bavaris7 Jul 24, 2014 1:51 PM
    innsbrooklad innsbrooklad Jul 24, 2014 2:03 PM Flag

    Great simile...This is a money machine..The new approval got no ink. Watch what they buy next.

  • innsbrooklad by innsbrooklad Jul 24, 2014 7:49 AM Flag

    There was a May 23rd article in the New York Times Sunday magazine entitled " Can the Nervous System Be
    Hacked." It goes into depth of the new science of bioelectronics. It is by far the best article I have read regarding
    the potential and where I think ETRM fits and how far ahead we may be.

  • Reply to

    Long term capital gains contributing to swoon

    by canphan7 Jul 23, 2014 12:37 PM
    innsbrooklad innsbrooklad Jul 24, 2014 7:15 AM Flag

    Please, that is just not true. Those folks are out or still owners. This company suffers from terrible IR/PR and management. PYBI had great Phase III data and the stock exploded. MACK had good data and what happened.
    Long term capital gains? Hardly.

    Stop making excuses for mediocre management. Makes you sound like an employee.

  • Reply to


    by crew_run Jul 23, 2014 12:17 PM
    innsbrooklad innsbrooklad Jul 23, 2014 2:41 PM Flag

    This is the strangest company I have ever owned. It has the first device that is actually a therapeutic, was deemed safe and will be approved. It has cutting edge science in the new field of bioelectronics. We have a good inventory of institutional investors and we traffic in obesity, the worst disease in the U.S.

    The quiet is necessary as the FDA has us under review.

  • Reply to

    Zydelig approved

    by ray_crucet Jul 23, 2014 2:29 PM
    innsbrooklad innsbrooklad Jul 23, 2014 2:37 PM Flag

    And the market gives it no credit...Billion dollar drugs must now be the rule!

  • Reply to


    by innsbrooklad Jul 22, 2014 5:11 PM
    innsbrooklad innsbrooklad Jul 22, 2014 9:06 PM Flag

    Does anyone out there have a comment? This is why I sold all my stock. We have no idea what is happening at MACK and I feel neither does management. If 398 and 121 were so good why is this stock trading here?
    Hey own a slug of PBYI. You own a ton of MACK...What are we all missing?

23.48-0.21(-0.89%)Jul 29 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.